Podcast
Questions and Answers
What is the alternate chemical name for nystatin?
What is the alternate chemical name for nystatin?
What is the mechanism of action (MOA) of nystatin?
What is the mechanism of action (MOA) of nystatin?
Why is nystatin only a topical antifungal drug?
Why is nystatin only a topical antifungal drug?
What antifungal is similar in structure to nystatin?
What antifungal is similar in structure to nystatin?
Signup and view all the answers
Which antifungal drug is often the drug of choice to treat a disseminated or invasive fungal infection in an immunocompromised patient?
Which antifungal drug is often the drug of choice to treat a disseminated or invasive fungal infection in an immunocompromised patient?
Signup and view all the answers
Which of the following pairs is most correct regarding antifungal mechanisms?
Which of the following pairs is most correct regarding antifungal mechanisms?
Signup and view all the answers
What is the definition of 'tinea'?
What is the definition of 'tinea'?
Signup and view all the answers
Which antifungal drug functions by inhibiting CYP450 (14 alpha demethylase)?
Which antifungal drug functions by inhibiting CYP450 (14 alpha demethylase)?
Signup and view all the answers
Which statement about squalene epoxidase inhibition is correct?
Which statement about squalene epoxidase inhibition is correct?
Signup and view all the answers
What is the primary action of echinocandins like caspofungin?
What is the primary action of echinocandins like caspofungin?
Signup and view all the answers
Which of the following drugs works as a mitotic inhibitor by disrupting microtubules?
Which of the following drugs works as a mitotic inhibitor by disrupting microtubules?
Signup and view all the answers
What is a primary characteristic of the mechanism of action for flucytosine?
What is a primary characteristic of the mechanism of action for flucytosine?
Signup and view all the answers
In what scenario is flucytosine primarily used in clinical practice?
In what scenario is flucytosine primarily used in clinical practice?
Signup and view all the answers
What pharmacokinetic adjustment is necessary for flucytosine?
What pharmacokinetic adjustment is necessary for flucytosine?
Signup and view all the answers
Which of the following correctly describes how amphotericin B's formulations affect toxicity?
Which of the following correctly describes how amphotericin B's formulations affect toxicity?
Signup and view all the answers
What is the primary adverse effect associated with flucytosine when combined with amphotericin B?
What is the primary adverse effect associated with flucytosine when combined with amphotericin B?
Signup and view all the answers
What mechanism do some fungi employ to resist flucytosine?
What mechanism do some fungi employ to resist flucytosine?
Signup and view all the answers
Which of the following statements about the pharmacokinetics of flucytosine is accurate?
Which of the following statements about the pharmacokinetics of flucytosine is accurate?
Signup and view all the answers
What negative impact does flucytosine have on intestinal flora?
What negative impact does flucytosine have on intestinal flora?
Signup and view all the answers
What is the primary function of amphotericin B in treating fungal infections?
What is the primary function of amphotericin B in treating fungal infections?
Signup and view all the answers
Which of the following characteristics is unique to amphotericin B compared to nystatin?
Which of the following characteristics is unique to amphotericin B compared to nystatin?
Signup and view all the answers
What is the source organism for the production of nystatin?
What is the source organism for the production of nystatin?
Signup and view all the answers
What is an adverse reaction commonly associated with intravenous administration of amphotericin B?
What is an adverse reaction commonly associated with intravenous administration of amphotericin B?
Signup and view all the answers
Which patient population is most likely to receive amphotericin B as a treatment option?
Which patient population is most likely to receive amphotericin B as a treatment option?
Signup and view all the answers
What is the pharmacokinetic profile of amphotericin B regarding liver or kidney function?
What is the pharmacokinetic profile of amphotericin B regarding liver or kidney function?
Signup and view all the answers
What is the major sterol that amphotericin B binds to in fungal cells?
What is the major sterol that amphotericin B binds to in fungal cells?
Signup and view all the answers
How is amphotericin B typically administered?
How is amphotericin B typically administered?
Signup and view all the answers
What is a key characteristic of azole antifungals in terms of mechanism of action?
What is a key characteristic of azole antifungals in terms of mechanism of action?
Signup and view all the answers
Which azole drug is specifically known for lacking the specificity for fungal CYP 450 compared to human CYP 450?
Which azole drug is specifically known for lacking the specificity for fungal CYP 450 compared to human CYP 450?
Signup and view all the answers
What type of infections are commonly treated with itraconazole and voriconazole?
What type of infections are commonly treated with itraconazole and voriconazole?
Signup and view all the answers
What is a notable adverse effect associated with azole antifungals?
What is a notable adverse effect associated with azole antifungals?
Signup and view all the answers
Which of the following statements accurately describes the pharmacokinetics of azole antifungals?
Which of the following statements accurately describes the pharmacokinetics of azole antifungals?
Signup and view all the answers
What distinguishes echinocandins from azoles in terms of their structure?
What distinguishes echinocandins from azoles in terms of their structure?
Signup and view all the answers
Which antifungal agent currently has no reported mechanisms of resistance?
Which antifungal agent currently has no reported mechanisms of resistance?
Signup and view all the answers
What is an important clinical consideration for azole antifungals concerning their interaction with human enzymes?
What is an important clinical consideration for azole antifungals concerning their interaction with human enzymes?
Signup and view all the answers
Match each antifungal to its description
Match each antifungal to its description
Signup and view all the answers
What is the mechanism of action (MOA) for echinocandins?
What is the mechanism of action (MOA) for echinocandins?
Signup and view all the answers
Which of the following are oral antifungals for mucocutaneous infections?
Which of the following are oral antifungals for mucocutaneous infections?
Signup and view all the answers
What is the mechanism of action (MOA) for griseofulvin?
What is the mechanism of action (MOA) for griseofulvin?
Signup and view all the answers
What is the mechanism of action (MOA) for terbinafine?
What is the mechanism of action (MOA) for terbinafine?
Signup and view all the answers
Which of the following are topical antifungals? (Select all that apply)
Which of the following are topical antifungals? (Select all that apply)
Signup and view all the answers
Flucytosine is non-water soluble.
Flucytosine is non-water soluble.
Signup and view all the answers
Which azole has the strongest interaction with CYP450?
Which azole has the strongest interaction with CYP450?
Signup and view all the answers
Study Notes
History of Nystatin
- E.L Hazen discovered a Streptomyces bacterium in the soil of Walter B. Nourses' garden in 1948
- Hazen named the bacterium Streptomyces noursei
- It took 14 years for penicillin to be ready for human use, because of the need to grow the bacterium in sufficient quantity, extract the active agent from the media, identify, purify and test the active agent
- Hazen grew cultures of Streptomyces noursei and then sent the broth to Rachel Brown in Albany, NY, for chemical isolation
- Hundreds of Mason jars were shipped by USPS without any breakage or losses
- In 1950, the drug was called nystatin (New York State Division of Laboratories)
- The drug was approved by the FDA in 1954
- Hazen and Brown held the patent for the drug in 1957
- Nystatin forms pores in the cell walls of fungi
Systemic Antifungal Drugs
Amphotericin B
- Isolated from Streptomyces nodosus
- It is a non-water soluble amphoteric polyene macrolide
- Amphotericin B has 7 double bonds in its structure, compared to 6 in Nystatin A
- Amphotericin B binds to Ergosterol, a sterol found only in fungal cell walls
- Cholesterol is the major sterol found in human and bacterial cells
- The drug forms an open pore in the fungal cell wall, making ions leak out of the cell and causing cell death
- Amphotericin B is only administered intravenously
- It has a half-life of 15 days
- It is slowly metabolized and does not require dose adjustment for hepatic or renal impairment
- Amphotericin B has a broad spectrum of activity, and is effective against various yeast species, including:
- Candida albicans
- Cryptococcus neoformans
- It is the drug of choice for all life-threatening mycotic infections
- IV dose dependent adverse effects include: fever, chills, muscle spasms, vomiting, hypertension
- Slower induction can cause renal damage
- Amphotericin B liposome and other lipid-bound formulations decrease the binding of the drug to human cell membranes, thus lowering toxicity
- Mechanism of resistance includes:
- Decreasing drug binding to ergosterol by decreasing membrane concentration of ergosterol
- Reducing the binding affinity of ergosterol for the drug
Flucytosine
- Flucytosine is a water-soluble synthetic pyrimidine analogue
- Fungal intracellular enzymes convert flucytosine to a phosphorylated active compound
- The phosphorylated analogue inhibits DNA and RNA synthesis
- Human cells are unable to phosphorylate flucytosine
- Flucytosine dose is 100 - 150 mg/d/kg orally
- Dose adjustment is required for renal failure
- Concentrations should be monitored to maintain levels of 50 - 100 ug/mL to avoid toxicity and ensure efficacy
- Flucytosine possesses a narrow range of activity and is clinically effective against:
- Cryptococcus neoformans
- Some Candida species
- It is only used in combination with other drugs to avoid resistance
- Adverse effects can include: Intestinal flora biotransformation of the drug into the toxic antineoplastic drug, fluorouracil
- Bone marrow toxicity is a risk, especially when combined with amphotericin B
- Mechanism of resistance includes: altered (reduced) metabolism (phosphorylation) of the drug, common in monotherapy
Azoles
- Synthesized imidazoles and triazoles
- Examples include:
- Ketoconazole
- Fluconazole
- They reduce fungal synthesis of ergosterol by inhibiting fungal CYP 450 enzymes
- Specificity is achieved through the drug’s greater affinity for fungal CYP450 compared to human CYP 450
- Ketoconazole lacks this specificity and is no longer used except as a topical
- Pharmacokinetics varies widely between the various azole drugs
- Azoles have a broad range spectrum of activity
- Clinical uses include:
- Many Candida species
- Endemic mycoses
- Dermatophytes
- Aspergillus (itraconazole and voriconazole)
- Relatively non-toxic, with minor GI disturbances
- All may induce abnormal liver function
- All inhibit human CYP450 to some extent and cause drug-drug interactions
- Mechanism of resistance includes:
- Multiple mechanisms with ever increasing frequency
- Imidazoles: ketoconazole, miconazole, clotrimazole
- Triazoles: itraconazole, fluconazole, voriconazole, posaconazole
Echinocandins
- Synthetic cyclic peptides
- Examples include:
- Caspofungin (Cancidas®)
- Micafungin
- Anidulafungin
- Inhibit the synthesis of beta (1,3)-D glucan in fungal cell walls, an essential component of the fungal cell wall
- They do not interfere with human cell wall biosynthesis or function
- They are administered intravenously
- Have a long half life allowing for once a day dosing
- They are effective against Candida species and the Aspergillus species
- Adverse effects predominantly mild GI disturbances
Topical Antifungal Agents
- Nystatin (world’s first antifungal)
- Topical azoles: clotrimazole, miconazole
- Topical Allylamines: terbinafine, naftifine
Summary of Drug Mechanisms
Polyenes (amphotericin B)
- Binds to ergosterol in cell wall
- Cell wall develops pores, leaks, and cell lysis occurs
Azoles (ketoconazole, fluconazole etc)
- Inhibits CYP450 (14 alpha demethylase)
- Decreases ergosterol production
- Weak cell walls develop leading to leaks and cell lysis
Echinocandins (caspofungin)
- Inhibits D-glucan synthesis
- Cell wall becomes weak causing leaks and cell lysis
DNA or Protein Synthesis (flucytosine)
- Flucytosine is metabolized to 5-flucytosine
- 5-flucytosine is incorporated into fungal RNA and protein synthesis is stopped
Squalene epoxidase inhibitor (terbinafine)
- Inhibits squalene epoxidase enzyme
- Squalene accumulates, which is toxic to the fungal cell
Mitotic Inhibitor (griseofulvin)
- Binds to new keratin in skin
- Blocks new infection by inhibiting fungal mitosis through microtubule disruption
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on the pharmacological aspects of nystatin, specifically its alternate chemical name. This quiz will challenge your understanding of antifungal medications and their classifications.